Accelerate Drug Candidate Identification
A computational chemist at a pharmaceutical company is tasked with finding novel inhibitors for a newly identified cancer protein target. Instead of months of traditional lab screening, they use an AI biotechnology platform. They input the 3D structure of the target protein, and the AI performs a virtual screening of a library containing millions of small molecules. Within 48 hours, the tool provides a ranked list of the top 100 compounds with the highest predicted binding affinity and lowest off-target effects. This allows the research team to focus their physical lab experiments on a small, highly promising set of candidates, reducing discovery time by over 90%.
